Showing results (61-70 of 157) with videos related to
Sort By:
Pageof 16
Clinical Chemistry and Laboratory Medicine|April 1, 2024
Patients with antiphospholipid syndrome and a first venous or arterial thrombotic event: clinical characteristics, antibody profiles and estimate of the risk of recurrenceVittorio Pengo, Luca Sarti, Emilia Antonucci, et al.Journal of Thrombosis and Thrombolysis|March 17, 2009
Use of D-dimer testing to determine duration of anticoagulation, risk of cardiovascular events and occult cancer after a first episode of idiopathic venous thromboembolism: the extended follow-up of the PROLONG studyBenilde Cosmi, Cristina Legnani, Alberto Tosetto, et al.Thrombosis and Haemostasis|March 31, 2010
Comorbidities, alone and in combination with D-dimer, as risk factors for recurrence after a first episode of unprovoked venous thromboembolism in the extended follow-up of the PROLONG studyBenilde Cosmi, Cristina Legnani, Alberto Tosetto, et al.Journal of Medicinal Chemistry|March 16, 2011
The identification of the 2-phenylphthalazin-1(2H)-one scaffold as a new decorable core skeleton for the design of potent and selective human A3 adenosine receptor antagonistsDaniela Poli, Daniela Catarzi, Vittoria Colotta, et al.European Heart Journal. Cardiovascular Pharmacotherapy|August 28, 2020
Off-label use of reduced dose direct oral factor Xa inhibitors in subjects with atrial fibrillation: a review of clinical evidenceMario Bo, Alberto Corsini, Enrico Brunetti, et al.BMJ Open|November 28, 2020
Bleeding and thrombotic complications during treatment with direct oral anticoagulants or vitamin K antagonists in venous thromboembolic patients included in the prospective, observational START2-registerGualtiero Palareti, Emilia Antonucci, Cristina Legnani, et al.Therapeutic Advances in Drug Safety|January 6, 2022
Do women with venous thromboembolism bleed more than men during anticoagulation? Data from the real-life, prospective START-RegisterGualtiero Palareti, Cristina Legnani, Emilia Antonucci, et al.Thrombosis and Haemostasis|December 7, 2021
Management of DOAC in Patients Undergoing Planned Surgery or Invasive Procedure: Italian Federation of Centers for the Diagnosis of Thrombotic Disorders and the Surveillance of the Antithrombotic Therapies (FCSA) Position PaperAlessandro Squizzato, Daniela Poli, Doris Barcellona, et al.International Journal of Cardiology|April 24, 2024
Machine learning approach for prediction of outcomes in anticoagulated patients with atrial fibrillationAndrea Bernardini, Luca Bindini, Emilia Antonucci, et al.Annals of Internal Medicine|October 20, 2010
Patient-level meta-analysis: effect of measurement timing, threshold, and patient age on ability of D-dimer testing to assess recurrence risk after unprovoked venous thromboembolismJames Douketis, Alberto Tosetto, Maura Marcucci, et al.Pageof 16